Literature DB >> 6133735

Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

D G McDevitt.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6133735     DOI: 10.2165/00003495-198325040-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  63 in total

1.  A test which may demonstrate in man, intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs [proceedings].

Authors:  J D Harry; M F Knapp; R J Linden; C P Newcombe; J B Stoker
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

3.  A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.

Authors:  J J McNeil; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  Abrupt withdrawal of pindolol or metoprolol after chronic therapy.

Authors:  E Szécsi; S Kohlschütter; W Schiess; E Lang
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Practolol treatment in asthmatics.

Authors:  H J Waal-Manning; F O Simpson
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

6.  Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.

Authors:  G Cocco; C Strozzi; D Chu; R Amrein; E Castagnoli
Journal:  Eur J Cardiol       Date:  1979-07

7.  Pindolol in orthostatic hypotension: possible therapy?

Authors:  D B Frewin; P P Leonello; R K Penhall; L Hughes; P E Harding
Journal:  Med J Aust       Date:  1980-02-09       Impact factor: 7.738

8.  Propranolol rebound--a retrospective study.

Authors:  R A Shiroff; J Mathis; R Zelis; D W Schneck; J D Babb; D M Leaman; A H Hayes
Journal:  Am J Cardiol       Date:  1978-04       Impact factor: 2.778

9.  Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.

Authors:  R C Hill; P Turner
Journal:  Br J Pharmacol       Date:  1969-06       Impact factor: 8.739

10.  Mechanism of propranolol withdrawal phenomena.

Authors:  S Nattel; R E Rangno; G Van Loon
Journal:  Circulation       Date:  1979-06       Impact factor: 29.690

View more
  8 in total

1.  Pharmacokinetic-pharmacodynamic modelling of oxprenolol in man using continuous non-invasive blood pressure monitoring.

Authors:  R Koopmans; B Oosterhuis; J M Karemaker; J Wemer; C J van Boxtel
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  [How many beta-receptor blockers does the physician need?].

Authors:  D Palm
Journal:  Klin Wochenschr       Date:  1987-03-16

Review 3.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

4.  Atenolol in the treatment of essential hypertension.

Authors:  C Piddisi; I Cerskus
Journal:  Can Fam Physician       Date:  1986-09       Impact factor: 3.275

5.  Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.

Authors:  G D Johnston; M B Finch; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Polymorphic metabolism of beta-adrenoceptor antagonists.

Authors:  J H Silas; M S Lennard; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

7.  Influence of intravenous beta-adrenergic blockade with or without partial agonist activity upon plasma cyclic AMP and catecholamines in healthy subjects.

Authors:  C Gennari; G Pollavini; R Nami; G Francini; C Bianchini; P Verdecchia
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Pharmacodynamic and pharmacokinetic studies on bufuralol in man.

Authors:  T H Pringle; R J Francis; P B East; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.